Market Place
Sourcing Support
Tokyo Court To Rule On Fortis Arm IHH And Daiichi Sankyo Dispute
29 Apr 2026 //
ECONOMICTIMES
Daiichi Sankyo Shares Slip After Delaying Annual Earnings Report
24 Apr 2026 //
BIOSPACE
Daiichi Sankyo Names Global Chief Corporate Affairs Officer
16 Apr 2026 //
FIRSTWORD PHARMA
Daiichi Sankyo plots $1.5B consumer health unit sale to Suntory
16 Apr 2026 //
PRESS RELEASE
Wayfinder Biosciences Advances Collaboration with Daiichi Sankyo
15 Apr 2026 //
FIRSTWORD PHARMA
ATLATL, Daiichi Sankyo Partner to Boost APAC Biotech
08 Apr 2026 //
PR NEWSWIRE
Nuvation Bio Acquires Japan Rights to Safusidenib from Daiichi
01 Apr 2026 //
PR NEWSWIRE
Voro Therapeutics Announces Research Collaboration With Daiichi
17 Mar 2026 //
BUSSINESSWIRE
Daiichi Sankyo Appoints John Tsai, MD as Global Head of R&D
19 Feb 2026 //
BUSINESSWIRE
Daiichi Sankyo Navigates Complexity of Success
27 Jan 2026 //
FIERCE PHARMA
Daiichi Sankyo Appoints Leaders at European Translational Center
22 Jan 2026 //
BUSINESSWIRE
DATROWAY Ph 3 TROPION-Lung17 Trial Initiated in NSCLC Cancer
13 Jan 2026 //
BUSINESSWIRE
Tempus Achieves Record Total Contract Value Exceeding $1.1 B
11 Jan 2026 //
BUSINESSWIRE
Daiichi taps Genesis to help market Vanflyta in Europe
07 Jan 2026 //
PHARMIWEB
FDA Approves Roche`s ENHERTU for HER2+ Metastatic Breast Cancer
16 Dec 2025 //
PR NEWSWIRE
Lunit, Daiichi Sankyo Partner To Advance Ai Biomarker Discovery
15 Dec 2025 //
PR NEWSWIRE
Therapy Eases Side Effects for 75% of Black Breast Cancer
10 Dec 2025 //
BUSINESSWIRE
Allegro, American Regent Sign 35M Synoglide Deal in Animal Health
25 Nov 2025 //
GLOBENEWSWIRE
Daiichi Sankyo Establishes Third Research Institute In San Diego
02 Oct 2025 //
BUSINESSWIRE
Daiichi Starts Development of Oral Triple Lipid-Lowering Combo
31 Aug 2025 //
BUSINESSWIRE
Soriot plots move of AZ stock listing to US: The Times
02 Jul 2025 //
FIERCE PHARMA
DATROWAY® approved in US for advanced EGFR-mutated lung cancer
24 Jun 2025 //
BUSINESSWIRE
Enhertu Phase 3 Trial Begins for HER2+ Endometrial Cancer
09 Jun 2025 //
BUSINESSWIRE
Datroway Shows Promising Tumor Responses in Lung Cancer
01 Jun 2025 //
BUSINESSWIRE
Endeavour Lung Program Launches Four Global Projects
23 May 2025 //
BUSINESSWIRE
Malaysia`s IHH unit seeks $1.3 billion from Daiichi Sankyo
20 May 2025 //
REUTERS
AZ, Daiichi`s Enhertu tops SOC in early-stage breast cancer
08 May 2025 //
FIERCE PHARMA
Daiichi Sankyo honors its roots at DC cherry blossom fest
17 Apr 2025 //
FIERCE PHARMA
CHMP Recommends ENHERTU For HER2 Low/Ultralow Metastatic Breast Cancer
28 Feb 2025 //
BUSINESSWIRE
Daiichi Sankyo Appoints Okuzawa as Chief Executive Officer
30 Jan 2025 //
BUSINESSWIRE
Quantum-Wild Ph 3 VANFLYTA® Trial Initiated for Newly Diagnosed AML
10 Dec 2024 //
BUSINESSWIRE
AstraZeneca, Daiichi share data behind Dato-DXd do-over
06 Dec 2024 //
FIERCE BIOTECH
Daiichi Sankyo Highlights Oncology Progress at ESMO, SABCS & ASH
02 Dec 2024 //
BUSINESSWIRE
Daiichi Sankyo Joins LabCentral Community as Platinum Sponsor
22 Nov 2024 //
PR NEWSWIRE
NICE says AZ, Daiichi failed to propose fair price on Enhertu
19 Nov 2024 //
FIERCE PHARMA
Daiichi Sankyo to Showcase TURALIO® at CTOS for Giant Cell Tumor
13 Nov 2024 //
BUSINESSWIRE
AZ, Daiichi promote better care for Black breast cancer patients
15 Oct 2024 //
FIERCE PHARMA
MILOS Study Highlights Bempedoic Acid`s Potential In Dyslipidemia
11 Oct 2024 //
EXPRESSPHARMA
ENHERTU Granted Priority Review For HER2 Low Breast Cancer
30 Sep 2024 //
BUSINESSWIRE
MILOS German Cohort Results Show Increase In LDL-C Goal With
27 Sep 2024 //
BUSINESSWIRE
AstraZeneca`s drug disappoints in breast cancer survival trial
23 Sep 2024 //
REUTERS
DS-9606 Shows Promise In Patients With Advanced Solid Tumors
15 Sep 2024 //
BUSINESSWIRE
AZ, Daiichi build case for Enhertu in breast cancer patients with brain metastases
14 Sep 2024 //
FEIRCE PHARMA
Daiichi study finds gender inequality in European cardiovascular care
03 Sep 2024 //
FIERCE PHARMA
Daiichi Sankyo Light on Inequalities and Unmet Needs With Cardio Disease
01 Sep 2024 //
BUSINESSWIRE
ENHERTU Gets US Breakthrough Status For HER2 Low/Ultralow Breast Cancer
19 Aug 2024 //
BUSINESSWIRE
EMA Validates ENHERTU For HER2 Low/Ultralow Metastatic Breast Cancer
19 Aug 2024 //
BUSINESSWIRE
Merck Advances Lung Cancer Strategy With Daiichi Deal And Combo Plans
06 Aug 2024 //
FIERCE BIOTECH
First Patient Dosed In IDeate-Lung02 Trial Of Ifinatamab Deruxtecan
03 Aug 2024 //
PHARMABIZ
IDeate-Lung02 Phase 3 Trial Of Ifinatamab Deruxtecan Initiated
01 Aug 2024 //
BUSINESSWIRE
Daiichi Sankyo Opens New Affiliate for Oncology in Greece
10 Jul 2024 //
BUSINESSWIRE
Without Pfizer appeal, Daiichi closes long-running ADC patent with $47M win
28 Jun 2024 //
FIERCE PHARMA
Arbitration Dispute Between Daiichi Sankyo and Seagen Ends
28 Jun 2024 //
BUSINESSWIRE
Daiichi Sankyo’s Ezharmia Receives Japanese Approval For T-Cell Lymphoma
25 Jun 2024 //
PHARMABIZ
Mika Collaborates with AstraZeneca and Daiichi for Breast Cancer Treatment
18 Jun 2024 //
GLOBENEWSWIRE
Bempedoic Acid Cut CVD Risk Across Patient Groups Per CLEAR Outcomes
29 May 2024 //
BUSINESSWIRE
RevolKa enters master service agreement with Daiichi Sankyo
29 May 2024 //
PHARMABIZ
RevolKa Signs Master Service Agreement with Daiichi Sankyo
28 May 2024 //
CONTRACT PHARMA
Tropion-Lung01: Nsclc Vs Chemo Clinically Meaningful Improvement
27 May 2024 //
BUSINESSWIRE
Holistic Cv Care Recommendations: From European Multidisciplinary Think Tank
27 May 2024 //
BUSINESSWIRE
